FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis, resulting in updates to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

SUPPL AP for MYFORTIC (MYCOPHENOLIC ACID)